How do healthtech startups sell to hospitals and health systems?

    ·Updated ·3 source episodes

    Health system deals move on specificity, not vision. Founders who win walk in with the buyer's own numbers, scope a single department, go live in weeks, and give the executive who owns that metric a reason to expand. Distribution, not the clinical insight, is the hard part of healthtech.

    What actually gets a health system deal moving?

    Every operator we have interviewed says the same thing in different words: generic AI positioning dies in committee. What survives is a quantified problem the buyer already recognizes, scoped small enough to prove inside a quarter.

    Specificity. Generic AI pitches die in committee. What moves is walking in with their own numbers: here is your call volume by department, here is your abandonment rate at eight in the morning, here is what that costs you in unbooked appointments per month.
    Imaad Rashied, VP of Health Systems at Assort Health·Episode 6

    Why is distribution harder than the clinical answer?

    Clinician founders arrive with an unfair advantage on the problem and a blind spot on the buying process. The pattern repeats across our clinical guests: the best clinical answer still has to be sold, implemented, and supported.

    Clinicians are trained to believe the best clinical answer wins, and in a company the best answer still has to be sold, implemented, and supported. I had to learn the enterprise sales cycle, the implementation timeline, and how a benefits leader is evaluated.
    Dr. Asima Ahmad, Co-Founder & Chief Medical Officer at Carrot Fertility·Episode 7
    Once you frame it as retention and equity rather than a perk, the buying conversation changes completely.
    Dr. Asima Ahmad, Co-Founder & Chief Medical Officer at Carrot Fertility·Episode 7

    Can a startup buy distribution at formation?

    One structural answer is to make the customer a co founder. Venture studios building alongside health systems trade equity for committed demand, which changes the risk profile of the whole company.

    In healthcare the hardest part is almost never the idea, it is the first ten customers. If you can solve distribution at formation, you change the risk profile of the entire company.
    John Beadle, Co-Founder & Managing Partner at Aegis Ventures·Episode 5
    We sit with the system's leadership and identify a problem they are willing to commit resources to, not just endorse.
    John Beadle, Co-Founder & Managing Partner at Aegis Ventures·Episode 5

    How does a departmental pilot become a system wide contract?

    Expansion is rarely a sales motion. It happens when frontline staff feel relief and the executive accountable for the metric sees it move.

    The clinic staff have to want it, which means the agent has to make their day quieter rather than create a new queue to clean up. Second, you need an executive sponsor who owns access as a metric.
    Imaad Rashied, VP of Health Systems at Assort Health·Episode 6

    Episodes this article draws on

    More from the archive

    This article is synthesized from Care Shift interviews and is updated as new episodes add material. Browse all episodes or read more about the show.